Dec 13 (Reuters) - Aspen Pharmacare Holdings Ltd APNJ.J :
* ASPEN PHARMACARE HOLDINGS LTD - ON TRACK TO MEET ITS FULL YEAR GUIDANCE OF COMMERCIAL PHARMA ORGANIC REVENUE GROWTH
* ASPEN - FY GUIDANCE OF COMMERCIAL PHARMA ORGANIC REVENUE GROWTH RANGING BETWEEN 1% AND 4% BASED ON PERFORMANCE FOR FIVE MONTHS TO 30 NOVEMBER 2018
* ASPEN - MANUFACTURING REVENUE FROM APIS HAS DONE BETTER THAN EXPECTED FOR FIVE MONTHS TO 30 NOVEMBER AND IS IN LINE WITH REVENUE FOR COMPARABLE PERIOD
* ASPEN PHARMACARE - POSITIVE PERFORMANCE FROM COMMERCIAL PHARMA IN MOST EMERGING MARKETS, JAPAN OFFSET BY WEAKER PERFORMANCE IN EUROPE & RUSSIA IN FY
* ASPEN PHARMACARE- SIGNIFICANT PROGRESS MADE IN PROCURING FULFILMENT OF CONDITIONS PRECEDENT TO DISPOSAL TO B.A.S. S.A. OF ASPEN'S NUTRITIONALS BUSINESS